{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:19:40Z","timestamp":1783171180669,"version":"3.54.6"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer US","isbn-type":[{"value":"9781071652015","type":"print"},{"value":"9781071652022","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5202-2_16","type":"book-chapter","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:43:44Z","timestamp":1783169024000},"page":"163-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chimeric RNAs as Novel Neoantigens for Extracellular Vesicles-Based Vaccines Against Cancer"],"prefix":"10.1007","author":[{"given":"Mengyuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,5]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","volume":"15","author":"J Liu","year":"2022","unstructured":"Liu J, Fu M, Wang M, Wan D, Wei Y, Wei X (2022) Cancer vaccines as promising immuno-therapeutics: platforms and current progress. J Hematol Oncol 15:28","journal-title":"J Hematol Oncol"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"N Xie","year":"2023","unstructured":"Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L (2023) Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther 8:9","journal-title":"Signal Transduct Target Ther"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrc.2016.154","volume":"17","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Johnson BA, Lutz ER, Laheru DA, Jaffee EM (2017) Targeting neoantigens to augment antitumour immunity. Nat Rev Cancer 17:209\u2013222","journal-title":"Nat Rev Cancer"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","volume":"38","author":"V Leko","year":"2020","unstructured":"Leko V, Rosenberg SA (2020) Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors. Cancer Cell 38:454\u2013472","journal-title":"Cancer Cell"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH et al (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23:703\u2013713","journal-title":"Nat Med"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J (2020) Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol 17:457\u2013474","journal-title":"Nat Rev Clin Oncol"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/01.HYP.11.1.21","volume":"11","author":"JA Oliver","year":"1988","unstructured":"Oliver JA (1988) Purification and partial characterization of canine angiotensinogen. Hypertension 11:21\u201327","journal-title":"Hypertension"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1158\/1078-0432.CCR-18-3169","volume":"25","author":"Y Lin","year":"2019","unstructured":"Lin Y, Dong H, Deng W et al (2019) Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Clin Cancer Res 25:3035\u20133045","journal-title":"Clin Cancer Res"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2016.07.006","volume":"2","author":"Y Jia","year":"2016","unstructured":"Jia Y, Xie Z, Li H (2016) Intergenically spliced chimeric RNAs in cancer. Trends Cancer 2:475\u2013484","journal-title":"Trends Cancer"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.10.052","volume":"501","author":"L Wang","year":"2021","unstructured":"Wang L, Xiong X, Yao Z et al (2021) Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer. Cancer Lett 501:1\u201311","journal-title":"Cancer Lett"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2159-8290.CD-12-0042","volume":"2","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Gong M, Yuan H, Park HG, Frierson HF, Li H (2012) Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation. Cancer Discov 2:598\u2013607","journal-title":"Cancer Discov"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1093\/nar\/gkx315","volume":"45","author":"Y Li","year":"2017","unstructured":"Li Y, Heavican TB, Vellichirammal NN, Iqbal J, Guda C (2017) ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-seq data. Nucleic Acids Res 45:e120","journal-title":"Nucleic Acids Res"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.18632\/oncotarget.1465","volume":"4","author":"H Zhang","year":"2013","unstructured":"Zhang H, Lin W, Kannan K, Luo L, Li J, Chao P-W, Wang Y, Chen Y-P, Gu J, Yen L (2013) Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma. Oncotarget 4:2135\u20132143","journal-title":"Oncotarget"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"e12243","DOI":"10.1002\/jev2.12243","volume":"11","author":"X Xiong","year":"2022","unstructured":"Xiong X, Ke X, Wang L et al (2022) Neoantigen-based cancer vaccination using chimeric RNA-loaded dendritic cell-derived extracellular vesicles. J Extracell Vesicle 11:e12243","journal-title":"J Extracell Vesicle"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/cells11020277","volume":"11","author":"Y Luo","year":"2022","unstructured":"Luo Y, Du L, Yao Z et al (2022) Generation and application of inducible chimeric RNA ASTN2-PAPPAas knockin mouse model. Cells 11:277","journal-title":"Cells"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1158\/2159-8290.CD-18-1357","volume":"9","author":"PA Ott","year":"2019","unstructured":"Ott PA, Wu CJ (2019) Cancer vaccines: steering T cells down the right path to eradicate tumors. Cancer Discov 9:476\u2013481","journal-title":"Cancer Discov"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","volume":"8","author":"T Fan","year":"2023","unstructured":"Fan T, Zhang M, Yang J, Zhu Z, Cao W, Dong C (2023) Therapeutic cancer vaccines: advancements, challenges, and prospects. Signal Transduct Target Ther 8:450","journal-title":"Signal Transduct Target Ther"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jconrel.2024.12.010","volume":"378","author":"Y Meng","year":"2025","unstructured":"Meng Y, Yao Z, Ke X, Hu M, Ren H, Gao S, Zhang H (2025) Extracellular vesicles-based vaccines: emerging immunotherapies against cancer. J Control Release 378:438\u2013459","journal-title":"J Control Release"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.aar7112","volume":"359","author":"U Sahin","year":"2018","unstructured":"Sahin U, T\u00fcreci \u00d6 (2018) Personalized vaccines for cancer immunotherapy. Science 359:1355\u20131360","journal-title":"Science"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1016\/j.cell.2022.10.006","volume":"185","author":"F Baharom","year":"2022","unstructured":"Baharom F, Ramirez-Valdez RA, Khalilnezhad A et al (2022) Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment. Cell 185:4317\u20134332. e15","journal-title":"Cell"},{"key":"16_CR21","doi-asserted-by":"crossref","unstructured":"Li K, Lin Y, Zhou Y, Xiong X, Wang L, Li J, Zhou F, Guo Y, Chen S, Chen Y, Tang H, Qiu X, Cai S, Zhang D,  Bremer E, Jim Yeung S-C, Zhang H (2023) Salivary extracellular MicroRNAs for early detection and prognostication of esophageal cancer: a clinical study Gastroenterology 165(4):932-945","DOI":"10.1053\/j.gastro.2023.06.021"},{"key":"16_CR22","doi-asserted-by":"crossref","unstructured":"Li K, Lin Y, Luo Y, Xiong X, Wang L, Durante K, Li J, Zhou F, Guo Y, Chen S, Chen Y, Zhang D, Jim Yeung S-C, Zhang H (2022) A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Molecular Cancer 21(1):21","DOI":"10.1186\/s12943-022-01499-8"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"101085","DOI":"10.1016\/j.drup.2024.101085","volume":"74","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Tu X, Hou X et al (2024) Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy. Drug Resist Updat 74:101085","journal-title":"Drug Resist Updat"},{"key":"16_CR24","doi-asserted-by":"crossref","unstructured":"Wu X, Meng Y, Yao Z, Lin X, Hu M, Cai S, Gao S, Zhang H (2025) Extracellular vesicles as nature's nano carriers in cancer therapy: insights toward preclinical studies and clinical applications. Pharmacol Res\u00a0217:107751","DOI":"10.1016\/j.phrs.2025.107751"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 13:e12404","journal-title":"J Extracell Vesicles"}],"container-title":["Methods in Molecular Biology","Chimeric RNAs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5202-2_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:43:48Z","timestamp":1783169028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5202-2_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652015","9781071652022"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5202-2_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"5 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}